AUDA (compound 43) is a potent soluble epoxide hydrolase (sEH) inhibitor with IC50s of 18 and 69 nM for the mouse and human sEH, respectively. AUDA has anti-inflammatory activity.
性状
Solid
IC50 & Target[1][2]
IC50: 18 nM (mouse sEH) and 69 nM (human sEH)
体外研究(In Vitro)
AUDA (0.3-10 μg/mL; 48 hours) dose-dependently suppresses the proliferation of rat VSMCs exposed to PDGF.
AUDA (0.3-10 μg/mL; 30 min) dose-dependently upregulats COX-2 expression.
AUDA (10, 50 and 100 μM) augments the migratory ability of HCAECs in a dose-dependent manner.
AUDA significantly increases the adhesion ability of HCAECs.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay
Cell Line:
Vascular smooth muscle cell (VSMC)
Concentration:
0.3, 1, 3, 10 μg/mL
Incubation Time:
48 hours
Result:
Dose-dependently suppressed the proliferation of rat VSMCs exposed to PDGF.